Skip to content
Rice-Based Cholera Vaccine

Rice-Based Cholera Vaccine

Oral vaccines are a great strategy and are especially beneficial in areas with poor sanitation. This form of vaccine distribution could help control the acute diarrheal disease caused by Vibrio cholera. There are an estimated 1.3 to 4 million cases and 21,000 to 143,000 deaths from cholera each year. A recent study from The Lancet Microbe finds new hope in a rice-based cholera vaccine that will fight against the diarrheal toxin without severe adverse events.

by Riley Bell

Read more at Promega Connections

Previous article Kilkenny company scoops major healthcare award for world-leading Covid-19 research
Next article Two COVID-19 Waves in Brazil Driven by Separate Lineages of SARS-CoV-2